Delpacibart Braxlosiran

BOSTON, MA, June 11, 2026 Curium Group, in collaboration with PeptiDream Inc. and PDRadiopharma Inc., has announced the completion...

BASEL, Switzerland, June 11, 2026 Novartis has announced positive results from the FORTITUDE Phase I/II clinical study evaluating delpacibart...